Brett Giroir
Search results
Norman Edward "Ned" Sharpless (born September 20, 1966) is the previous Director of the National Cancer Institute (NCI). Before that, Sharpless was Professor of Medicine and Genetics Chair, Director of University of North Carolina UNC Lineberger Comprehensive Cancer Center, Molecular Therapeutics, Wellcome Distinguished Professorship in Cancer ...
Apr 4, 2022 · Norman E. Sharpless, M.D., announced his decision to retire from his position as director of the National Cancer Institute (NCI) on April 4, 2022, after serving since 2017. He will continue as NCI director until April 29, 2022, to allow for a smooth transition.
Apr 4, 2022 · Dr. Norman E. “Ned” Sharpless, M.D., announced his decision to retire from his position as director of the NCI, part of the NIH, on April 4, 2022. He will continue as NCI director until April 29, 2022, to allow for a transition. He led the NCI's response to the COVID-19 pandemic and its equity and inclusion programs.
Apr 4, 2022 · President Joe Biden will get a chance to name a new head of U.S. cancer fighting efforts. Norman “Ned” Sharpless, director of the $6.9 billion National Cancer Institute (NCI) since late 2017, announced today that he will step down at the end of this month after nearly 5 years on the job.
Apr 4, 2022 · By The ASCO Post Staff. Posted: 4/4/2022 10:19:00 AM. Last Updated: 4/4/2022 10:52:29 AM. Norman E. Sharpless, MD, has announced that he has decided to step down from his position as Director of the National Cancer Institute (NCI), part of the National Institutes of Health, a position he has held since 2017. Dr.
Norman E. Sharpless, M.D. Biography. Norman E. Sharpless, M.D. (he/him) . Director, National Cancer Institute . Dr. Norman E. “Ned” Sharpless was officially sworn in as the 15. th. Director of the National Cancer Institute (NCI) on October 17, 2017.
Oct 18, 2017 · Dr. Norman E. Sharpless, M.D., is the 15th director of the National Cancer Institute (NCI), part of the National Institutes of Health. He succeeds Harold E. Varmus, M.D., who stepped down in 2015. He is an outstanding scientist, clinician, and administrator who specializes in the molecular biology of cancer and aging.
